Arjo AB (FRA:A39) FFO


FRA:A39 Arjo AB FRA:A39
72 GF Score
Price €2.21
GF Value €3.24
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Arjo AB FFO?

FFO (Funds from operations) only applies to REITs.

FRA:A39
72GF Score
Arjo AB FRA:A39
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Arjo AB (FRA:A39) Overvalued in 2026?

Based on GuruFocus' analysis, Arjo AB stock appears to be undervalued. The current stock price of €2.21 is trading 31.7% below its estimated GF Value™ of €3.24. GuruFocus considers Arjo AB to be Significantly Undervalued.

Key valuation signals for FRA:A39:

  • FFO:
  • GF Value™: €3.24 vs. price of €2.21 (31.7% below fair value)
  • GF Score™: 72/100 with 5 warning signs

No single metric tells the full story. See the FRA:A39 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Arjo AB Business Description

Address Hans Michelsensgatan 10, Box 48, Malmo, SWE, SE-201 20
Arjo AB is a supplier of medical devices, services, and solutions in Sweden. It serves its services to private and public institutions with acute care and long-term care. The company's offering includes products and solutions for patient handling, hygiene, disinfection, medical beds, therapeutic surfaces, venous thromboembolism (VTE) prevention and diagnostics. The company includes segments: Global Sales, North America, Diagnostics.
72GF Score

Get the complete analysis for FRA:A39

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.21
Price
€3.24
GF Value